SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-022569
Filing Date
2024-02-28
Accepted
2024-02-28 21:46:36
Documents
2
Period of Report
2024-02-22

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1639
2 EX-24.1 tcrt-ex24_1.htm EX-24.1 17110
  Complete submission text file 0000950170-24-022569.txt   20403
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MUSCLE MAKER, INC, 2200 SPACE PARK DRIVE,SUITE 310 HOUSTON TX 77058
Business Address
Groenewald Ferdinand (Reporting) CIK: 0001734018 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 24698520